Otolaryngology Doctors in Oakdale, CA Accepting Medicare

1 Otolaryngology doctors found. Showing 1 - 1

Jerrold Polterock, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 250 S Oak Ave, Suite 4, Oakdale, CA 95361 Phone: 209-845-0100    Fax: 209-845-0130

News Archive

Absence of vision from birth leads to permanent state of pain hypersensitivity, shows report

Absence of vision from birth leads to a permanent state of pain hypersensitivity, reports PAIN. An international team of scientists investigated whether congenitally blind subjects experience pain differently than sighted individuals. Their results, published in the current issue of PAIN®, reveal compelling evidence that congenitally blind individuals are hypersensitive to pain caused by thermal stimuli.

Normal weight teens who perceive themselves as fat are more likely to become obese

They're everywhere - in magazines, on the Internet, on television-people with super-thin bodies who are presented as having the ideal body form. But despite the increasing pressure to be thin, more and more of us are overweight. Now, researchers from the Norwegian University of Science and Technology (NTNU) have found that normal weight teens who perceive themselves as fat are more likely to grow up to be fat.

Sebelius reiterates call for insurer transparency

Health and Human Services Secretary Kathleen Sebelius Monday "called on managed-care companies to publicly justify rate increases." Meanwhile, President Obama "cited a recent Wall Street conference call as evidence that the industry is willing and able to price out some customers." Sebelius' action came on the heels of last week's White House meeting with the executives of a number of major health insurance companies.

Marijuana use could pose serious cognitive function risk later in life

Marijuana is the most frequently used illicit drug in the United States, according to a recent survey from the National Survey on Drug Use and Health, and new data suggest that marijuana use now could pose a serious cognitive function risk later in life.

EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation

EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).

Read more Medical News

› Verified 3 days ago